Novo Nordisk has announced a number of executive changes including the appointment of current head of region China, Pacific & Marketing as executive vp and head of North America.
The company's ceo Lars Rebien Sorensen will also step down from 01 Jan 2017, to be succeeded by Lars Fruergaard Jorgensen.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Sep 16
